(INMB) - Corporate News

(INMB) – Corporate News

Apr 23, 2024 08:02 AM INmune Bio (INMB) Reports 24-Month Stability Validation of XPro for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
Apr 22, 2024 08:01 AM INmune Bio (INMB) Prices 572K Share Offering at $8.32/sh
Mar 5, 2024 08:05 AM
Jan 30, 2024 08:00 AM
Dec 18, 2023 04:01 PM
Nov 29, 2023 08:06 AM
Nov 27, 2023 08:03 AM
Nov 15, 2023 09:01 AM
Oct 17, 2023 08:00 AM
Sep 5, 2023 08:02 AM
May 8, 2023 08:04 AM
Apr 3, 2023 09:00 AM
Feb 8, 2023 08:46 AM
Jan 25, 2023 07:45 AM
Dec 6, 2022 04:02 PM
Nov 14, 2022 09:00 AM
Jun 16, 2022 08:04 AM
May 23, 2022 04:00 PM
May 10, 2022 08:03 AM
Apr 13, 2022 04:01 PM
Mar 3, 2022 04:00 PM
Sep 1, 2021 04:07 PM
Jul 22, 2021 11:55 AM
Jul 14, 2021 09:02 AM
Jun 14, 2021 04:04 PM
Jan 21, 2021 07:04 AM
Oct 5, 2020 09:08 AM
Sep 16, 2020 07:04 AM
Sep 3, 2020 09:04 AM
Sep 1, 2020 09:09 AM
Aug 13, 2020 09:02 AM
Jul 16, 2020 09:17 AM
Jul 13, 2020 04:18 PM
Jul 9, 2020 09:07 AM
Jun 11, 2020 09:03 AM
Apr 22, 2020 09:08 AM
Jan 2, 2020 09:09 AM
Nov 19, 2019 09:01 AM
Sep 12, 2019 08:32 AM
Jun 27, 2019 09:07 AM
Feb 4, 2019 10:48 AM